Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
about
Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?KASL clinical practice guidelines: management of hepatitis CClinical applications, limitations and future role of transient elastography in the management of liver disease.Imaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical ApproachControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaChronic hepatitis C and liver fibrosis.Clinical Application of Transient Elastography in the Diagnosis of Liver Fibrosis: an Expert Panel Review and OpinionExpanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDSTransient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectivesInfluence of hepatitis C virus and IL28B genotypes on liver stiffnessMicrofibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient CohortA secreted form of the asialoglycoprotein receptor, sH2a, as a novel potential noninvasive marker for liver fibrosisFibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis.Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B.Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis CElevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients.Non-invasive assessment of liver fibrosis in chronic hepatitis B.Real time shear wave elastography in chronic liver diseases: accuracy for predicting liver fibrosis, in comparison with serum markers.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.Evaluation of cervical stiffness during pregnancy using semiquantitative ultrasound elastographyA health technology assessment of transient elastography in adult liver disease.Non-invasive diagnosis of hepatitis B virus-related cirrhosisEgy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study.ESR statement on the stepwise development of imaging biomarkers.Performance of liver stiffness measurements by transient elastography in chronic hepatitis.Non-invasive markers for hepatic fibrosisNon-invasive assessment of liver fibrosis in chronic hepatitis C.A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosisOccult cirrhosis diagnosed by transient elastography is a frequent and under-monitored clinical entity.Late presentation of chronic viral hepatitis for medical care: a consensus definitionDiagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitisControlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.Matrix Mechanosensing: From Scaling Concepts in 'Omics Data to Mechanisms in the Nucleus, Regeneration, and Cancer.Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UKEgy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting.Hepatitis C virus infection in the human immunodeficiency virus infected patient.
P2860
Q26744631-23F82A6F-8BD4-4176-9D39-320CFDE83C71Q26752471-D9B992E9-60D8-42C0-B03F-B2A174FFA0E4Q26768262-11251F23-C4AB-4D5E-A8CF-8A94F8A9AD95Q26771433-C218D866-78B6-4C04-8900-12522A6917C9Q26772324-8B6FDA47-A62C-4470-B8C7-9CB2152A456EQ26825671-18A90B5F-E09C-4DA9-941B-B858C9F2E3F3Q26852557-CDBB3FEE-9FD2-4C97-B5D3-F3D8A7231824Q27004509-CF7489FB-BDE9-4E40-A3D8-50D53E432EDAQ28079445-D20902C4-E074-4B24-935A-A84A4C783192Q28085479-95D49DEA-7A92-4DE7-95D6-57ABE59FC5B5Q28542906-021A4E9F-B4E4-4148-AE66-533F344639C2Q28550209-5F066E85-448B-468F-9B4F-DE7B28E4CD6CQ28742875-A6BECA27-67E4-4B40-A6B5-D4D872850BC3Q30362068-2F8B7CE3-EFAF-410C-8185-62827B010009Q30374820-9D00CF98-7742-4140-B2B7-8CCBC56E66D2Q30383907-D95DDC73-3840-4EB8-B88A-3316B1635B46Q30386788-A05F3427-0AC4-4CEA-B0C9-C1FD8F2C1A39Q30422199-6B78800C-40F4-4D3F-9897-E86621261F7AQ30426477-BA262950-FF4F-430B-9BF4-5DA466B449D0Q30427489-0414B83B-8A19-4B1E-880F-48E8F7E84A5BQ30428521-08218862-52E7-4F8C-AA00-2A6690C560A9Q30430774-6F4B78F1-E093-4848-8AF8-D82D845BFB24Q30431037-84FA306D-3764-41DF-9BBF-DC7828C1EEE5Q30442208-2CF97DEE-0CA1-4FAA-A447-48BF77798D9EQ30442641-391B68AD-01E4-4C59-AF56-D8FA79BA53F5Q30449245-85EECAFF-CC45-424B-8938-0D12271B5890Q30456007-4FBCCC88-E99B-4577-82FE-F661661C82BDQ30459104-EA087B7B-893D-40C6-9465-D2DA01278E99Q30474093-6ECDE0CF-90B2-4A5F-90A9-4BBFAFDE3A2CQ30474738-090AA28F-0E8A-4C08-AAEB-D028B08835EFQ31157282-800DDCB0-785D-43B2-9C6B-587B71D9AAEAQ33420367-4C5F9F24-37A5-4CFE-B3AD-E992920923C6Q33630076-2DF1E371-A5D2-4190-A1AF-C459404CB6A3Q33652009-0834578A-0AFC-465B-A62E-5623D7DD172DQ33718346-A86A49DE-3D23-491D-8B86-86793DA6A162Q33726992-0C66150B-D40F-4FCA-B52F-F87A8AFE3B97Q33795154-2ED83066-F53F-41DF-939C-5980C6C87308Q33796032-651C6852-0401-4DE1-B960-92D7A4B54DF7Q33805907-633D212B-DCD0-4EC0-A9F0-EB5F95A9D568Q34168504-9CA98776-9308-481A-B72C-99E5A6ADAB4A
P2860
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Diagnostic accuracy of FibroSc ...... e study (the FIBROSTIC study).
@en
Diagnostic accuracy of FibroSc ...... multicenter prospective study
@nl
type
label
Diagnostic accuracy of FibroSc ...... e study (the FIBROSTIC study).
@en
Diagnostic accuracy of FibroSc ...... multicenter prospective study
@nl
prefLabel
Diagnostic accuracy of FibroSc ...... e study (the FIBROSTIC study).
@en
Diagnostic accuracy of FibroSc ...... multicenter prospective study
@nl
P2093
P1476
Diagnostic accuracy of FibroSc ...... e study (the FIBROSTIC study).
@en
P2093
Amel Mahmoudi
Bruno Roche
FIBROSTIC study group
Francoise Degos
Hélène Voitot
Julien Asselineau
Paul Perez
P304
P356
10.1016/J.JHEP.2010.05.035
P577
2010-08-14T00:00:00Z